While the deal between Atlanta-based Aveanna and Maryland-based Maxim won't go forward, the fact that it drew FTC's attention shows how closely the agency is watching for consolidation issues in the marketplace.
from Kaiser Health News https://ift.tt/2RQD3Bs
February 03, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Fentanyl-Linked Deaths: The U.S. Opioid Epidemic’s Third Wave On Morning Edition Thursday, WBUR’s Martha Bebinger discusses the soaring death toll due to fentanyl, a powerful synthetic opioid that can shut down breathing in less than a minute. Public health experts are calling this the… Read More
In Third Suit Against Medicaid Work Requirements, Plaintiffs Say Trump Administration Is ‘Bypassing Legislative Process’New Hampshire residents are challenging the Trump administration’s approval of work requirements for Medicaid recipients, after suits filed in Arkansas and Kentucky. Critics of the work requirement waivers say they are an att… Read More
CDC Report Paints Grim Picture Of Rapidly Escalating Fentanyl Overdoses That Have Hit Vulnerable Communities HardThe death rate among African Americans from fentanyl-involved drug overdoses rose 141 percent each year, on average, from 2011 to 2016, and the death rate for Hispanics rose 118 percent in that period every year on average. A… Read More
Curtain Pulled Back On Group Behind Deluge Of Public Comments Over HHS’ Proposal To End Rebate SystemMore than 5,000 of the currently 18,000 comments were made public this week, and nearly all of them support the proposal with very similar wording that matches a RetireSafe-sponsored form letter available at the website Submi… Read More
Against The Backdrop Of Persistently High Suicide Rates, Program Finds Success With Veterans Helping Veterans During A CrisisAuthorities are touting a Los Angeles County program as a breakthrough in policing that could save lives of veterans who are having a crisis. Since the program’s launch in September, local law enforcement agencies answering s… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment